The concept of meta-epidemiology has been introduced because of the methodological limitations of the systematic review of clinical trials of intervention. Metaepidemiology has moved from a statistical method to a new methodology to close gaps between evidence and practice, controlling the potential biases in quantitative systematic review and drawing appropriate evidence to establish evidence-based guidelines. Network metaepidemiology has been suggested to overcome some limitations of meta-epidemiology. This review aims to clarify the concept and major methods to conduct a metaepidemiological study.
Introduction
Owing to the recent advances to overcome the limitations of systematic review (SR), 'meta-epidemiology' has been proposed as a new methodology aimed at investigating the conflicting results of a SR with the same hypothesis, as well as the problems inherent in the research process, such as heterogeneity, publication bias, allocation concealment or post-allocation patient blinding, which make it difficult to provide a rationale for the results of a SR and drawing of appropriate conclusions.
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The term 'meta-epidemiology' can be defined as a 'statistical method' to analyze the influence of qualitative problems in randomized clinical trials and their confounding variables. In randomized clinical trials, the topics of traditional epidemiological studies are the individuals, while the topics of meta-epidemiological studies are the original articles of randomized clinical trials and observational studies.
3-5 Table 1 shows the characteristics of meta-epidemiological studies.
Meta-epidemiology is based on the combination of two concepts: epidemiology and metaanalysis. To adjust the purposes of those two concepts, metaepidemiology strains to: (A) describe the distribution of the research evidence for a specific question; (B) examine heterogeneity and risk factors associated; and (C) control the biases between studies and summarize the research evidence. Considering such model, several methods, such as meta-regression, imputation, lack of informational odds ratio, double statistical models, have been tested, the term 'meta-epidemiology' being thus introduced. 3, 6, 7 Meta-epidemiological studies analyze the articles of randomized clinical trials and observational studies, meta-meta-epidemiologic studies analyze the metaepidemiologic studies, and network meta-epidemiology analyzes the metaanalyses of published randomized clinical trials, whose data were analyzed with a statistical method valid for indirect comparisons or network metaanalysis, also called multiple-treatment or mixedtreatment comparison metaanalysis. Table 2 shows the major characteristics of meta-epidemiological, metameta-epidemiological and network meta-epidemiological studies. 3 Recently there was a trend towards the application of the potentials of confounding meta-variables, such as genotype, study design, number of participants, generation of allocation sequence, allocation, concealment, blinding, placebo-control vs. no treatment control, exclusion of patients, randomization, effect size, single-center vs. multicenter study, and experimental vs. observational study. 
References
Meta-epidemiological studies have limitations: study results allow for a dichotomous analysis and continuous results cannot be managed; if the number of study subjects is reduced, the statistical power is limited; and indirect comparisons cannot be applied. Aiming at overcoming such limitations, the term 'network meta-epidemiology' has been proposed to emphasize how to make direct comparisons when several types of interventions are assessed. Therefore, developing research tools, Copas parametric model, graphs presented and published items are paramount for their conduction. In a study assessing 31 metaanalyses on cardiovascular biomarkers (C-reactive protein, non-HDL-cholesterol, lipoprotein(a), post-load glucose, fibrinogen, B-type natriuretic peptide and troponins), the prognostic effect was significantly stronger in observational studies than in randomized clinical trials. Cardiovascular biomarkers often have less promising results in the evidence derived from randomized clinical trials than from observational studies.
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Conclusion
This topic is extremely new, generating new questions that fill the gaps in this type of investigation. In addition, this challenging topic requires new methodologies for science advance.
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